Latest Close
$2.95
News
IXHL
Incannex Healthcare Inc. News
This news view pulls recent coverage and headlines tied to IXHL.
1y Change
-$28.55 (-90.63%)
Market Cap
$35,295,436.00
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Recommendation
none
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
GlobeNewswire • Jul 23, 2026
Read articleIncannex (IXHL) Secures U.S. Patent Grant in Obstructive Sleep Apnea for IHL-42X
Insider Monkey • Jul 15, 2026
Read articleIncannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea
MT Newswires • Jun 25, 2026
Read articleIncannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
GlobeNewswire • Jun 25, 2026
Read articleIncannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility
GlobeNewswire • Jun 10, 2026
Read articleIncannex Announces Initiation of Research Coverage by Alliance Global Partners
GlobeNewswire • Jun 9, 2026
Read article